PINL:GRPOF - Post by User
Comment by
PCR1917on Aug 07, 2018 1:24pm
79 Views
Post# 28422065
RE:RE:RE:RE:RE:At last fair analysis for Tetra. Taking knowledge
RE:RE:RE:RE:RE:At last fair analysis for Tetra. Taking knowledge frobin2 wrote: It would only make sense to buy TBP than to venture on their own, especially with TBP so far ahead of the competition as far as trials, having a great relationship with FDA and Health Canada, and their arrangement with the major distributor not named yet, would only make Canopy's life a lot easier.
Now - this is a hypothetical situation and TBP senses that a buy out offer is on the horizon, is it wise for them to manipulate the stock at a higher price before hand or continue to short it? I don't know finances well enough to be positive, but I would think a higher SP would mean the company has a higher market value resulting in a higher buy out price? Please correct me if I'm wrong.
I would answer you by a question: who has more money to manipulate the share price, a little biopharma like tbp to have a higher offer or a larger player (pharma or big lp) to pay a lower price?